iiinova — where your digital self keeps evolving

Nicolas Bery

@nicolasbery.bsky.social

103 followers 205 following 2 posts

Research scientist at Cancer Research Centre of Toulouse/Inserm | Pancreatic cancer, intracellular antibody, biodegrader, PPI | Views are my own

Posts Replies Media

Reposted by Nicolas Bery

Laurel Oldach @laureloldach.bsky.social · 13/01/2026

Meanwhile, in the lab: intratumor vaccination (or, if you will, "chemical reprogramming") guided by a PD-L1 degrader, all wrapped into one molecule cen.acs.org/pharmaceutic...

cen.acs.org

A targeted protein degrader that doubles as a cancer vaccine

One molecule combines two approaches to waken dormant immunity against tumors

041

Reposted by Nicolas Bery

MarkGHScott @markghscott.bsky.social · 19/07/2025

I am organizing a Special Issue in Cancers with Eric Chastre & Larissa Kotelevets on PTEN Regulation. 7 papers published so far and deadline is fixed for 31 Dec 2025. Please reach out if you are interested in contributing.

042

Reposted by Nicolas Bery

Audrey Lumeau @audreylumeau.bsky.social · 07/03/2025

Delighted to share our new preprint revealing a novel mechanism of ATR inhibitor sensitivity linked to lethal origin firing, thanks Sarah @mcclellandlab.bsky.social and collaborators!

032

Reposted by Nicolas Bery

Waggoner Lab @labwaggoner.bsky.social · 06/03/2025

VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation www.cell.com/cell-chemica...

0102

Reposted by Nicolas Bery

Eric Topol @erictopol.bsky.social · 01/03/2025

3 points of progress vs pancreatic cancer! 1. Neoantigen vaccines www.nature.com/articles/s41... 2. KRAS drugs www.wsj.com/health/healt... 3. Early diagnosis www.science.org/doi/10.1126/...

841384

Reposted by Nicolas Bery

Eric Topol @erictopol.bsky.social · 12/02/2025

A different kind of Pac-Man! An innovative, rapid nanosensor assay to help diagnose early pancreatic cancer in people at high-risk (PAC-MANN) www.science.org/doi/10.1126/...

science.org

Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay

A high-throughput, noninvasive, rapid protease-activated nanosensor identifies patients with pancreatic cancer in a small volume of blood.

526567

Nicolas Bery @nicolasbery.bsky.social · 18/01/2025

Congrats @lmkdassama.bsky.social and all co-authors for this comprehensive review on biodegraders! A must read.

101

Reposted by Nicolas Bery

Alessio Ciulli @alessiociulli.bsky.social · 08/12/2024

Happy to share our latest review on SOCS proteins and their role and therapeutic potential as targets in immunology. To date, drug discovery targeting SOCS proteins have been elusive, due to the difficulty to drug their polar SH2 domain.. 1/3 www.frontiersin.org/journals/imm...

frontiersin.org

Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins

1111

Nicolas Bery @nicolasbery.bsky.social · 04/12/2024

It was a great pleasure to present @CellSymposia #CSchembio2024 our work on intracellular biodegraders in beautiful San Francisco!! Thanks to the organisers for this opportunity! @mariesorbara.bsky.social

321